International Clinical Trial: A Clinical Trial in Healthy Children to Study if the Yellow Fever Vaccine Manufactured by Serum Institute of India is Safe and Generates Comparable Antibody Response When Compared to a Licensed Yellow Fever Vaccine

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (CTRI/2026/10/119251) titled 'A Clinical Trial in Healthy Children to Study if the Yellow Fever Vaccine Manufactured by Serum Institute of India is Safe and Generates Comparable Antibody Response When Compared to a Licensed Yellow Fever Vaccine' on Oct. 9.

Study Type: Interventional

Study Design: Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Centralized Blinding and masking:Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

Primary Sponsor: Serum Institute of India Pvt Ltd

Intervention: Inte...